Bako Diagnostics
Christopher Toomey is an accomplished Sales Account Manager at Bako Diagnostics since March 2021, bringing a wealth of experience in the pharmaceutical and medical sales sectors. Previous roles include Specialty Sales Consultant at Alfasigma, where Christopher cultivated extensive product knowledge and engaged healthcare professionals in discussions on clinical evidence and safety profiles. As a Womens Health Sales Representative at Ferring Pharmaceuticals, Christopher successfully re-launched Cervidil in Southern California, exceeding performance goals and enhancing hospital efficiency through strategic educational initiatives. Prior experience includes Territory Manager at EMSI, Account Executive and Assistant Manager at Enterprise Rent-A-Car, and Financial Service Representative at MetLife. Christopher holds a Bachelor of Science in Business Management from Farmingdale State College and an Associate of Arts from Nassau Community College.
This person is not in any offices
Bako Diagnostics
Bako Diagnostics is a provider of diagnostic and therapeutic services with a unique focus on pathology of the lower extremity. Bako’s comprehensive testing menu includes ENFD Analysis, Mass Spectrometry, for rapid identification of bacteria from culture specimens, and Molecular Genetics for the detection of micro-organisms and as a diagnostic aid in certain pathologic diagnoses. Bako’s in-network services are available through its more than 200 million covered lives, including all five national health plans and fully compliant patient-friendly billing policies. Over the past nine years, Bako has evolved into one of the podiatric profession’s principal sources of educational sponsorship. Bako Diagnostics, your professional partner for disease diagnostics and management! For more information, call us at 855-422-5628 or visit bakodx.com.